| # | Drug | Count |
|---|---|---|
| 0 | METOPROLOL TARTRATE | 13 |
| 1 | ASPIRIN | 11 |
| 2 | ASPIRIN 325 MG | 11 |
| 3 | ASPIRIN 81 MG | 11 |
| 4 | FUROSEMIDE | 11 |
| 5 | MYCOPHENOLATE MOFETIL | 11 |
| 6 | ADALIMUMAB | 10 |
| 7 | ATENOLOL | 10 |
| 8 | VALSARTAN | 10 |
| 9 | HYDROCHLOROTHIAZIDE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BROMOCRIPTINE MESYLATE | 2 | 0.0031 |
| 1 | TOPICAL ANESTHETIC | 2 | 0.0025 |
| 2 | BENZOCAINE | 2 | 0.0020 |
| 3 | ALOSETRON HYDROCHLORIDE | 1 | 0.0012 |
| 4 | BUPRENORPHINE HCL | 1 | 0.0011 |
| 5 | LAMIVUDINE AND ZIDOVUDINE | 5 | 0.0006 |
| 6 | BISMUTH SUBSALICYLATE | 3 | 0.0005 |
| 7 | DHEA (DEHYDROEPIANDROSTERONE) | 1 | 0.0005 |
| 8 | DEFEROXAMINE MESYLATE | 1 | 0.0005 |
| 9 | LOPINAVIR AND RITONAVIR | 6 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 22 |
| 1 | Angiotensin 2 Receptor Blocker [EPC] | 20 |
| 2 | Benzodiazepine [EPC] | 15 |
| 3 | beta-Adrenergic Blocker [EPC] | 13 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 12 |
| 5 | Corticosteroid [EPC] | 11 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 11 |
| 7 | Loop Diuretic [EPC] | 11 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 11 |
| 9 | Vitamin C [EPC] | 10 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 8 | 0.0002 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 8 | 0.0001 |
| 2 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 8 | 0.0001 |
| 3 | Angiotensin 2 Receptor Blocker [EPC] | 20 | 0.0001 |
| 4 | Thiazide Diuretic [EPC] | 9 | 0.0000 |
| 5 | beta-Adrenergic Blocker [EPC] | 13 | 0.0000 |
| 6 | Dihydropyridine Calcium Channel Blocker [EPC] | 11 | 0.0000 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 12 | 0.0000 |
| 8 | Mood Stabilizer [EPC] | 7 | 0.0000 |
| 9 | Loop Diuretic [EPC] | 11 | 0.0000 |